Pharmacyclics (PCYC)

Add to Watchlists Create an Alert
85.61 +0.01  +0.01%   NASDAQ May 24, 8:00PM BATS Real time Currency in USD

Pharmacyclics Revenue Quarterly YoY Growth:

47.69% for Sept. 30, 2012
View Full Chart

Pharmacyclics Revenue Quarterly YoY Growth Chart

    Pharmacyclics Historical Revenue Quarterly YoY Growth Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 2   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    March 31, 2013 47.69%
    Sept. 30, 2012 277454%
    June 30, 2012 53.17%
    March 31, 2012 -6.41%
    Dec. 31, 2011 2659%
    Sept. 30, 2011 -98.12%
    June 30, 2011 -44.40%
    March 31, 2011 -2.51%
    Dec. 31, 2010 -39.94%
    Sept. 30, 2010
    June 30, 2010
    March 31, 2010
    Dec. 31, 2009
    Sept. 30, 2009
    June 30, 2009
    March 31, 2009
    Dec. 31, 2008
    Sept. 30, 2008
    June 30, 2008
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
    Dec. 31, 2006 Go Pro
       
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro
    June 30, 2005 Go Pro
    March 31, 2005 Go Pro
    Dec. 31, 2004 Go Pro
    Sept. 30, 2004 Go Pro
    June 30, 2004 Go Pro
    March 31, 2004 Go Pro
    Dec. 31, 2003 Go Pro
    Sept. 30, 2003 Go Pro
    June 30, 2003 Go Pro
    March 31, 2003 Go Pro
    Dec. 31, 2002 Go Pro
    Sept. 30, 2002 Go Pro
    June 30, 2002 Go Pro
    March 31, 2002 Go Pro
    Dec. 31, 2001 Go Pro
    Sept. 30, 2001 Go Pro
    June 30, 2001 Go Pro
    March 31, 2001 Go Pro
    Dec. 31, 2000 Go Pro
    Sept. 30, 2000 Go Pro

    About Revenue Growth

    Revenue growth illustrates sales increases/decreases over time. It is used to measure how fast a business is expanding. More valuable than a snapshot of revenue, revenue growth helps investors identify trends in order to gauge revenue growth over time.

    If a company generated $75 billion in revenue during 2008 and $100 billion in revenue during 2009, the company experienced roughly a ($100 billion/$75 billion)-1 = %33 increase in revenue.
    Learn More

    Get data for

    PCYC Revenue Quarterly YoY Growth Benchmarks

    Companies
    Johnson & Johnson 8.46%
    Catalyst Pharmaceutical Partners
    Endo Health Solutions 2.59%

    PCYC Revenue Quarterly YoY Growth Rankings

    Overall 94th percentile
    402 of 7600
    Sector 87th percentile
    82 of 653 in Healthcare
    Industry 84th percentile
    10 of 66 in Drug Manufacturers - Specialty & Generic

    PCYC Revenue Quarterly YoY Growth Range, Past 5 Years

    Minimum -98.12% Sep 2011
    Maximum 277454% Sep 2012
    Average 31114%